testosterone undecanoate has been researched along with Obesity in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 16 (80.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doros, G; Haider, A; Haider, KS; Saad, F | 1 |
| Aftab, S; Ali, A; Barber, TM; Dimitriadis, GK; Grammatopoulos, DK; Hattersley, JG; Jones, TH; Mastorakos, G; Pandey, S; Randeva, HS; Valsamakis, G | 1 |
| Clarke, M; Grossmann, M; Hoermann, R; Ng Tang Fui, M; Nolan, B; Zajac, JD | 1 |
| Allan, C; Atlantis, E; Bracken, K; Conway, A; Daniel, M; Gebski, V; Grossmann, M; Hague, W; Handelsman, DJ; Inder, W; Jenkins, A; Keech, A; McLachlan, R; Robledo, K; Stuckey, B; Wittert, G; Yeap, BB | 1 |
| Doros, G; Haider, A; Saad, F; Traish, AM | 1 |
| Aversa, A; Bruzziches, R; Francomano, D; Ilacqua, A; Lenzi, A | 1 |
| Morales, A | 1 |
| Bhartia, M; Cole, N; Hackett, G; Kennedy, D; Raju, J; Wilkinson, P | 1 |
| Aversa, A; Barbaro, G; Bruzziches, R; Francomano, D; Lenzi, A | 1 |
| Doros, G; Hammerer, PG; Yassin, AA; Yassin, DJ | 1 |
| Dupuis, P; Gianatti, EJ; Grossmann, M; Hoermann, R; Strauss, BJ; Wentworth, JM; Zajac, JD | 1 |
| Dupuis, P; Gianatti, EJ; Grossmann, M; Hoermann, R; Zajac, JD | 1 |
| Carbone, MD; De Pergola, G; Giagulli, VA; Guastamacchia, E; Licchelli, B; Ramunni, MI; Sabbà, C; Triggiani, V | 1 |
| Almehmadi, Y; Nettleship, JE; Salman, M; Yassin, AA | 1 |
| Khupulsup, K; Leelaphiwat, S; Pavavattananusorn, S; Permpongkosol, S; Petchthong, T; Thongpradit, S | 1 |
| Dupuis, P; Grossmann, M; Ng Tang Fui, M; Prendergast, LA; Raval, M; Strauss, BJ; Zajac, JD | 1 |
| Aversa, A; Bruzziches, R; Di Luigi, L; Fornari, R; Francomano, D; Greco, EA; Lenzi, A; Migliaccio, S | 1 |
| Boneva, Z; Boyanov, MA; Christov, VG | 1 |
| Nieschlag, E; Zitzmann, M | 1 |
| Björntorp, P; Krotkiewski, M; Mårin, P | 1 |
9 trial(s) available for testosterone undecanoate and Obesity
| Article | Year |
|---|---|
Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trial.
Topics: Adaptor Proteins, Signal Transducing; Bone Density; Bone Morphogenetic Proteins; Caloric Restriction; Femur; Genetic Markers; Humans; Lumbar Vertebrae; Male; Middle Aged; Obesity; Testosterone | 2018 |
Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trial.
Topics: Affect; Aged; Androgens; Body Composition; Diabetes Mellitus, Type 2; Double-Blind Method; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Hand Strength; Health Care Costs; Humans; Insulin; Lower Urinary Tract Symptoms; Male; Middle Aged; Obesity; Overweight; Patient Acceptance of Health Care; Testosterone; Weight Reduction Programs | 2019 |
Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.
Topics: Adult; Aged; Androgens; Body Composition; Body Mass Index; Delayed-Action Preparations; Depressive Disorder; Diabetes Mellitus, Type 2; Double-Blind Method; Erectile Dysfunction; Glycated Hemoglobin; Humans; Hypogonadism; Insulin Resistance; Male; Middle Aged; Obesity; Testosterone; Young Adult | 2014 |
Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial.
Topics: Abdominal Fat; Adult; Aged; Androgens; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Double-Blind Method; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Injections, Intramuscular; Insulin Resistance; Male; Middle Aged; Obesity; Testosterone | 2014 |
Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial.
Topics: Adult; Aged; Aging; Androgens; Depression; Diabetes Mellitus, Type 2; Double-Blind Method; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Libido; Male; Middle Aged; Obesity; Placebos; Testosterone; Treatment Outcome | 2014 |
Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial.
Topics: Absorptiometry, Photon; Adipose Tissue; Body Composition; Body Weight; Combined Modality Therapy; Diet, Reducing; Double-Blind Method; Humans; Male; Middle Aged; Obesity; Testosterone | 2016 |
Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study.
Topics: Aged; Androgens; Bone Density; Femur; Humans; Hypogonadism; Male; Metabolic Syndrome; Middle Aged; Obesity; Spine; Testosterone | 2012 |
Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
Topics: Androgens; Blood Glucose; Body Composition; Diabetes Mellitus, Type 2; Erectile Dysfunction; Homeostasis; Hormone Replacement Therapy; Humans; Libido; Male; Middle Aged; Obesity; Testosterone | 2003 |
Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.
Topics: Adult; Body Mass Index; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Nonlinear Dynamics; Obesity; Pharmacogenetics; Receptors, Androgen; Regression Analysis; Testosterone; Testosterone Congeners; Trinucleotide Repeats | 2007 |
11 other study(ies) available for testosterone undecanoate and Obesity
| Article | Year |
|---|---|
Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from
Topics: Aged; Anthropometry; Blood Pressure; Cardiovascular Diseases; Humans; Hypogonadism; Injections; Lipids; Longitudinal Studies; Male; Middle Aged; Mortality; Obesity; Overweight; Registries; Testosterone; Weight Loss | 2020 |
Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy.
Topics: Adult; Blood Glucose; Body Composition; Glycated Hemoglobin; Hormone Replacement Therapy; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Obesity; Phenotype; Pilot Projects; Prospective Studies; Testosterone; Treatment Outcome | 2018 |
Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.
Topics: Adult; Aged; Androgens; Blood Glucose; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Fasting; Glycated Hemoglobin; Humans; Hypogonadism; Lipid Metabolism; Long-Term Care; Male; Metabolic Syndrome; Middle Aged; Obesity; Organ Size; Prostate; Registries; Testosterone; Treatment Outcome; Triglycerides | 2014 |
Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome.
Topics: Aged; Androgens; Humans; Hypogonadism; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Middle Aged; Obesity; Testosterone; Time Factors; Treatment Outcome | 2014 |
Editorial comment.
Topics: Androgens; Humans; Hypogonadism; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Obesity; Testosterone | 2014 |
Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study.
Topics: Blood Pressure; Body Composition; Cardiovascular System; Carotid Intima-Media Thickness; Diet, Reducing; Endothelium, Vascular; Exercise; Fibrinogen; Glucose Tolerance Test; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hypogonadism; Lipids; Male; Middle Aged; Obesity; Pilot Projects; Testosterone | 2014 |
Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
Topics: Aged; Androgens; Body Composition; Body Mass Index; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Erectile Dysfunction; Humans; Hypogonadism; Male; Metabolic Syndrome; Middle Aged; Obesity; Penile Erection; Prospective Studies; Quality of Life; Testosterone; Triglycerides; Waist Circumference | 2014 |
Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Glycated Hemoglobin; Hormone Replacement Therapy; Humans; Hypoglycemic Agents; Hypogonadism; Incretins; Liraglutide; Male; Metformin; Middle Aged; Obesity; Penile Erection; Retrospective Studies; Risk Reduction Behavior; Testosterone; Time Factors; Treatment Outcome; Weight Loss | 2015 |
Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Aging; Androgens; Body Mass Index; Body Weight; Cardiovascular Diseases; Erectile Dysfunction; Follow-Up Studies; Humans; Hypogonadism; Male; Middle Aged; Obesity; Prospective Studies; Quality of Life; Reproductive Health; Risk Factors; Surveys and Questionnaires; Testosterone; Waist Circumference; Young Adult | 2017 |
Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
Topics: Aged; Androgens; Bone Density; Drug Administration Schedule; Follow-Up Studies; Humans; Hypogonadism; Libido; Lipoproteins, HDL; Male; Middle Aged; Obesity; Orgasm; Patient Satisfaction; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Testosterone; Triglycerides; Waist Circumference | 2016 |
Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues.
Topics: Adipose Tissue; Biopsy; Body Composition; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Evaluation; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Muscles; Obesity; Testosterone | 1992 |